| Lovastatin as a Neuroprotective Treatment for Early Stage Parkinson's Disease (NCT03242499) | National Taiwan University Hospital | 2017-05-15 |
| Study of Bosutinib in Japanese Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (NCT03128411) | Pfizer | 2017-05-15 |
| Adjuvant Capecitabine vs Gemcitabine Plus Cisplatin in Resected Extrahepatic Cholangiocarcinoma (NCT03079427) | Asan Medical Center | 2017-05-15 |
| Safety and Efficacy of Dalbavancin Versus Active Comparator in Adult Patients With Osteomyelitis (NCT03091439) | Allergan | 2017-05-15 |
| TEMCAP in Grade 3 and Low Ki-67 Gastroenteropancreatic Neuroendocrine Tumors (NCT03079440) | Asan Medical Center | 2017-05-15 |
| Study to Test the Safety, Tolerability and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia Gravis (NCT03052751) | UCB Biopharma S.P.R.L. | 2017-05-15 |
| Omega-3 Fatty Acids Plus Low-dose Aspirin Daily Supplementation in Surgical Therapy to Treat Aggressive Periodontitis (NCT03093207) | Universidade Estadual Paulista Júlio de Mesquita Filho | 2017-05-15 |
| A Study of Acute Graft-Versus-Host Disease (GVHD) in Patients Undergoing Allogeneic Stem-Cell Transplantation (NCT02737306) | CytoDyn, Inc. | 2017-05-14 |
| Deciphering Antitumour Response and Resistance With INtratumour Heterogeneity (NCT02314481) | University College, London | 2017-05-12 |
| Use of High Dose Radiation Followed by Chemotherapy and Radiation to Treat Locally Advanced NSCLC (NCT03141359) | Wake Forest University Health Sciences | 2017-05-12 |
| Efficacy and Safety of Dalbavancin Compared to Standard of Care Antibiotic Therapy for the Completion of Treatment of Patients With Complicated Bacteremia or Infective Endocarditis (NCT03148756) | AbbVie | 2017-05-12 |
| A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of Children With Idiopathic Short Stature (NCT03255694) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2017-05-12 |
| Extension Study of NT-501 Ciliary Neurotrophic Factor (CNTF) Implant for Macular Telangiectasia (MacTel) (NCT03071965) | Neurotech Pharmaceuticals | 2017-05-12 |
| Hydroxyurea Management in Kids: Intensive Versus Stable Dosage Strategies (NCT03020615) | St. Jude Children's Research Hospital | 2017-05-12 |
| A Study to Evaluate the Safety, Tolerability and Efficacy of a Liproca® Depot Injection in Patients With Prostate Cancer (NCT03348527) | Lidds AB | 2017-05-12 |
| Influence of a Food Supplement on the Gut Microbiome in Healthy Obese Women (NCT03223987) | Bio-Strath AG | 2017-05-11 |
| Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation (NCT03047629) | Enterin Inc. | 2017-05-11 |
| Lanreotide in the Treatment of Small Bowel Motility Disorders (NCT03012594) | Northwell Health | 2017-05-11 |
| Eltrombopag Combined With Cyclosporine as First Line Therapy in Patients With Severe Acquired Aplastic Anemia (NCT02998645) | Novartis Pharmaceuticals | 2017-05-11 |
| Low Dose Interleukin-2 in Patients With Stable Ischaemic Heart Disease and Acute Coronary Syndromes (NCT03113773) | Cambridge University Hospitals NHS Foundation Trust | 2017-05-11 |
| Ascending Dose Study of Genome Editing by the Zinc Finger Nuclease (ZFN) Therapeutic SB-913 in Subjects With MPS II (NCT03041324) | Sangamo Therapeutics | 2017-05-11 |
| Phase II Anetumab Ravtansine in Pre-treated Mesothelin-expressing Pancreatic Cancer (NCT03023722) | Yale University | 2017-05-11 |
| Study to Evaluate Efficacy and Safety of Sunitinib in Renal Cell Carcinoma Progressed to 1L Immunotherapy Treatment. (NCT03066427) | Spanish Oncology Genito-Urinary Group | 2017-05-10 |
| Autism Oxytocin Brain Project (NCT03033784) | Emory University | 2017-05-10 |
| Evaluation of SBRT for Patients With Locally Advanced Unresectable Pancreatic Cancer (NCT03158779) | Istituto Clinico Humanitas | 2017-05-10 |
| Study of IBI308 With Advanced/Metastatic Esophageal Squamous Cell Carcinoma After Failure of First-line Treatment (NCT03116152) | Innovent Biologics (Suzhou) Co. Ltd. | 2017-05-10 |
| A Randomized, Double-Blind Phase II Study of Adjuvant Pembrolizumab Versus Placebo in Head and Neck Cancers at High Risk for Recurrence- the PATHWay Study (NCT02841748) | University of Chicago | 2017-05-10 |
| A Trial to Study Neladenoson Bialanate Over 20 Weeks in Patients With Chronic Heart Failure With Preserved Ejection Fraction (NCT03098979) | Bayer | 2017-05-10 |
| Study of an Anti-TLR4 mAb in Rheumatoid Arthritis (NCT03241108) | Light Chain Bioscience - Novimmune SA | 2017-05-10 |
| Low Dose Plerixafor Plus G-CSF in Mobilizing Stem Cells for Autologous Peripheral Blood Transplantation (NCT03244930) | Hospital Universitario Dr. Jose E. Gonzalez | 2017-05-10 |
| Nivolumab and Ipilimumab and Radiation Therapy in MSS and MSI High Colorectal and Pancreatic Cancer (NCT03104439) | Massachusetts General Hospital | 2017-05-10 |
| Phase 1/2 Study of Ensartinib and Durvalumab, in ALK-rearranged Non-small Cell Lung Cancer (NCT02898116) | Ludwig Institute for Cancer Research | 2017-05-10 |
| Ramucirumab Plus FOLFIRI Versus Ramucirumab Plus Paclitaxel in Patients With Advanced or Metastatic Gastric Cancer, Who Failed One Prior Line of Palliative Chemotherapy (NCT03081143) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2017-05-10 |
| The Addition of Pembrolizumab to Postoperative Radiotherapy in Cutaneous Squamous Cell Cancer of the Head and Neck (NCT03057613) | Case Comprehensive Cancer Center | 2017-05-10 |
| Preoperative vs. Postoperative Rectal Misoprostol in Cesarean Section (NCT03148717) | Ain Shams University | 2017-05-10 |
| The p53 Colorectal Cancer Trial (NCT03149679) | Haukeland University Hospital | 2017-05-09 |
| Osimertinib and Gefitinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer (NCT03122717) | Dana-Farber Cancer Institute | 2017-05-09 |
| Saracatinib and Alcohol Drinking (NCT02955186) | Yale University | 2017-05-09 |
| Pemetrexed Disodium in Treating Patients With Previously Treated Metastatic Urothelial Cancer (NCT02693717) | M.D. Anderson Cancer Center | 2017-05-09 |
| Title: Therapeutic Targets in African-American Youth With Type 2 Diabetes (NCT02960659) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2017-05-09 |
| Optune® Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma (NCT02743078) | RTOG Foundation, Inc. | 2017-05-09 |
| Trial of Nab-paclitaxel in Patients With Desmoid Tumors and Multiply Relapsed/Refractory Desmoplastic Small Round Cell Tumors and Ewing Sarcoma (NCT03275818) | Grupo Espanol de Investigacion en Sarcomas | 2017-05-09 |
| A Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer's Disease (NCT03117738) | Nature Cell Co. Ltd. | 2017-05-09 |
| Proof-of-Concept Superiority Trial of Fosravuconazole Versus Itraconazole for Eumycetoma in Sudan (NCT03086226) | Drugs for Neglected Diseases | 2017-05-09 |
| Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff (NCT03110133) | Finch Research and Development LLC. | 2017-05-08 |
| Effect of Morphine on Dyspnea and 6-Minute Walk Distance in Pulmonary Arterial Hypertension (NCT03401476) | John Granton | 2017-05-08 |
| A Study to Evaluate Safety, PK and Efficacy of HS-10296 in Patients With NSCLC (NCT02981108) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2017-05-08 |
| Trial of Plitidepsin (Aplidin®) in Combination With Bortezomib and Dexamethasone in Multiple Myeloma Patients Double Refractory to Bortezomib and Lenalidomide (NCT03117361) | PharmaMar | 2017-05-08 |
| Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors (NCT03095248) | Children's Hospital Medical Center, Cincinnati | 2017-05-08 |
| PKB171 Against Placebo in Couples With Asthenozoospermia Who Wish to Conceive (NCT06986031) | Prokrea BCN, S.L. | 2017-05-08 |
| Phase 2 Study of Rivaroxaban Reversal by Ciraparantag as Measured by WBCT (NCT03172910) | Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc. | 2017-05-08 |
| Study of AZD9291 in NSCLC Patients Harboring T790M Mutation Who Failed EGFR TKI and With Brain and/or LMS (NCT03257124) | Samsung Medical Center | 2017-05-08 |
| Neo-adjuvant Chemotherapy With Letrozole in Patients With Estrogen Receptor Positive/HER-2 Negative Breast Cancer (NCT03497702) | National Cancer Center, Korea | 2017-05-08 |
| Nivolumab for Relapsed or Residual Haematological Malignancies After Allogeneic Stem Cell Transplantation (NCT03146468) | Melbourne Health | 2017-05-08 |
| A Study to Assess the Analgesic Efficacy and Safety of ASP8062 in Subjects With Fibromyalgia (NCT03092726) | Astellas Pharma Global Development, Inc. | 2017-05-08 |
| Optimal Sequencing of Treatment Options for Poor Risk mCRPC Previously Treated With Docetaxel (NCT03295565) | The Netherlands Cancer Institute | 2017-05-07 |
| Nitrite Infusion in Islet Cell Transplantation (NCT03544242) | University of Alabama at Birmingham | 2017-05-07 |
| A Study to Evaluate the Change in Weight After 24 Weeks Treatment With LIK066 in Obese or Overweight Adults (NCT03100058) | Novartis Pharmaceuticals | 2017-05-06 |
| The Efficacy and Safety of the Xue-Fu-Zhu-Yu Capsule in Treatment of Qi Stagnation and Blood Stasis Syndrome. (NCT03091634) | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | 2017-05-06 |
| Study of CPI-0610 in Patients With Malignant Peripheral Nerve Sheath Tumors (NCT02986919) | University of Texas Southwestern Medical Center | 2017-05-05 |
| APRIL CAR T Cells (AUTO2) Targeting BCMA and TACI for the Treatment of Multiple Myeloma (NCT03287804) | Autolus Limited | 2017-05-05 |
| SV-BR-1-GM in Metastatic or Locally Recurrent Breast Cancer (NCT03066947) | BriaCell Therapeutics Corporation | 2017-05-05 |
| Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants With Infantile Hemangioma (IH) (NCT02913612) | Kanecia Obie Zimmerman | 2017-05-05 |
| Paclitaxel and Bevacizumab With or Without Emactuzumab in Treating Patients With Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT02923739) | M.D. Anderson Cancer Center | 2017-05-05 |
| Phase 1b of ASLAN001 (Varlitinib) in Patients With Advanced/ Metastatic Hepatocellular Carcinoma (HCC) (NCT03499626) | National University Hospital, Singapore | 2017-05-05 |
| WEE1 Inhibitor AZD1775 With or Without Cytarabine in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome (NCT02666950) | Mayo Clinic | 2017-05-05 |
| Oxytocin and Brain Responses in Maternal Addiction (NCT02979093) | Lane Strathearn, MBBS PhD | 2017-05-05 |
| S-Equol in Alzheimer's Disease 2 Trial (NCT03101085) | Russell Swerdlow | 2017-05-05 |
| Endostar Combined With IP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas (NCT03797625) | Fudan University | 2017-05-04 |
| An Open-Label, Proof-of-Concept Study of Ixekizumab in the Treatment of Pyoderma Gangrenosum (NCT03137160) | Ohio State University | 2017-05-04 |
| Efficacy and Dose Ranging Study of Seroguard (NCT03660787) | Pharmasyntez | 2017-05-04 |
| Clinical Study of Apatinib and 5-Fu Combination Regimen to Treat Advanced Colorectal Cancer Patients (NCT03210064) | Hui ting Xu，MD | 2017-05-04 |
| Efficacy of Ketamine Infusion Compared With Traditional Anti-epileptic Agents in Refractory Status Epilepticus (NCT03115489) | University of Alabama at Birmingham | 2017-05-04 |
| Bronchodilator Effects and Safety of Glycopyrronium Bromide (25 ug and 50 ug o.d.) in Asthma (NCT03137784) | Novartis Pharmaceuticals | 2017-05-04 |
| A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression (NCT03044249) | Mediti Pharma Inc. | 2017-05-04 |
| OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules (NCT02872701) | On Target Laboratories, LLC | 2017-05-04 |
| First-In-Human Study of Monoclonal Antibody BMS-986218 by Itself and in Combination With Nivolumab in Participants With Advanced Solid Tumors (NCT03110107) | Bristol-Myers Squibb | 2017-05-04 |
| LEE011 Plus Everolimus in Patients With Metastatic Pancreatic Adenocarcinoma Refractory to Chemotherapy (NCT02985125) | Georgetown University | 2017-05-04 |
| Fungal Prophylaxis With Isavuconazole for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HCT) (NCT03149055) | Memorial Sloan Kettering Cancer Center | 2017-05-04 |
| Rapid Antidepressant Effects of ATP and Phosphocreatine (NCT03138681) | Zhujiang Hospital | 2017-05-03 |
| Does Dapagliflozin Provide Additional Health Benefits To Dietary Counseling For Weight Loss? (NCT03180489) | Christopher Bell | 2017-05-03 |
| Window of Opportunity Trial of Dasatinib in Operable Triple Negative Breast Cancers With nEGFR (NCT02720185) | University of Wisconsin, Madison | 2017-05-03 |
| Clinical Trial on the Combination of Avelumab and Axitinib for the Treatment of Patients With Recurrent Glioblastoma (NCT03291314) | Universitair Ziekenhuis Brussel | 2017-05-03 |
| A Study to Evaluate SHR-1210 in Patients With Advanced or Metastatic NSCLC (NCT03085069) | Jiangsu HengRui Medicine Co., Ltd. | 2017-05-03 |
| Study of IFN-K in Dermatomyositis (NCT02980198) | Neovacs | 2017-05-03 |
| Non-Invasive Diagnosis of Pulmonary Vascular Disease Using Inhaled 129Xe Magnetic Resonance Imaging (NCT03078192) | Bastiaan Driehuys | 2017-05-03 |
| Netupitant and Palonosetron Hydrochloride in Preventing Chronic Nausea and Vomiting in Patients With Cancer (NCT03040726) | M.D. Anderson Cancer Center | 2017-05-03 |
| Choline Alphoscerate-Nimodipine in Vascular Cognitive Impairment (NCT03228498) | Azienda Ospedaliero-Universitaria Careggi | 2017-05-02 |
| The Effective and Safety of Thalidomide in TI (NCT03184844) | Xiao-Lin Yin | 2017-05-02 |
| Carbidopa-levodopa in Neovascular AMD (NCT03022318) | Snyder, Robert W., M.D., Ph.D., P.C. | 2017-05-02 |
| A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001) (NCT03157128) | Eli Lilly and Company | 2017-05-02 |
| Evaluation of the Efficacy and Safety of Nal-IRI for Progressing Brain Metastases in Breast Cancer Patients (NCT03328884) | MedSIR | 2017-05-02 |
| A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Participants With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723) (NCT03085914) | Incyte Corporation | 2017-05-02 |
| Study to Evaluate the Efficiency of FOLFIRI as Seconde-line Chemotherapy in Neuroendocrine Carcinoma (NCT03168607) | Peking University | 2017-05-02 |
| Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing With DFD-06 (NCT03179605) | Primus Pharmaceuticals | 2017-05-02 |
| Study to Evaluate Vadadustat for Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Who Are Hyporesponsive to Erythropoiesis Stimulating Agents (NCT03140722) | Akebia Therapeutics | 2017-05-02 |
| Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer (NCT02779855) | H. Lee Moffitt Cancer Center and Research Institute | 2017-05-02 |
| Dose Ranging Study of Carbidopa-levodopa (NCT03023059) | Snyder, Robert W., M.D., Ph.D., P.C. | 2017-05-02 |
| Micro-mobile Foot Compression and Diabetic Foot (NCT03135535) | Baylor College of Medicine | 2017-05-02 |
| Mesylate Apatinib for Stage Ⅳ STS After Failure of Chemotherapy (NCT03121846) | Tianjin Medical University Cancer Institute and Hospital | 2017-05-01 |